Puriblood Medical Co., Ltd. (TPEX:6847)
74.10
+0.60 (0.82%)
Feb 11, 2026, 2:56 PM CST
Puriblood Medical Company Description
Puriblood Medical Co., Ltd. engages in the research and development of blood purification-related medical devices in Taiwan.
The company offers leukoreduction, cell separation, and P-Tex, an advanced anti-fouling technology, which is composed by bio-inspired molecular formula.
It is also involved in animal blood transfusion. Puriblood Medical Co., Ltd. was incorporated in 2015 and is based in Hsinchu City, Taiwan.
Puriblood Medical Co., Ltd.
| Country | Taiwan |
| Founded | 2015 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 44 |
| CEO | Yanwen Chen |
Contact Details
Address: No.11, Gongye E. 9th Rd Hsinchu City, 300096 Taiwan | |
| Phone | 886 3 668 7199 |
| Website | puriblood.com |
Stock Details
| Ticker Symbol | 6847 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006847007 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yanwen Chen | Chairman and President |
| Prof. Yung Chang | Founder and Consultant |
| Xiaowen Jiang Fang | Accounting Supervisor |